Silver Spring, Maryland—(ENEWSPF)—March 8, 2018
By: Theresa Eisenman
The U.S. Food and Drug Administration (FDA) approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).Trogarzo is administered intravenously once every 14 days by a trained medical professional and…
